Tatiana joined Oxford Science Enterprises in May 2023. She focuses on uncovering new opportunities in Health Tech and supporting the creation of new businesses and the existing portfolio.
Before OSE, Tatiana worked in strategy at a biotech company developing psychedelics for mental health disorders, where she provided in-depth analytic support for strategic decisions. Before this, Tatiana worked in healthcare investment banking as an Associate at Rothschild & Co. There, she worked on a broad range of transactions for private and public companies across Speciality Pharma, Biotech and MedTech sectors.
Tatiana holds a BSc in Neuroscience from the University of Bristol.